RA Capital Management’s Frazier Lifesciences Acquisition Corporation Unit FLACU Stock Holding History

RA Capital Management’s Portfolio FLACU Stock Details FLACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,000,000	Closed	-$9.98M	–	87
2022 Q3	$9.98M	Hold	1,000,000	–	–	0.21%	59
2022 Q2	$9.87M	Hold	1,000,000	–	–	0.26%	59
2022 Q1	$9.99M	Hold	1,000,000	–	–	0.22%	76
2021 Q4	$9.92M	Hold	1,000,000	–	–	0.17%	82
2021 Q3	$9.82M	Hold	1,000,000	–	–	0.14%	79
2021 Q2	$10.1M	Hold	1,000,000	–	–	0.16%	75
2021 Q1	$10.2M	Hold	1,000,000	–	–	0.15%	70
2020 Q4	$10.4M	Buy	+1,000,000	New	+$10.4M	0.15%	69

RA Capital Management's FLACU Position: Q4 2022 in Review

RA Capital Management sold out of Frazier Lifesciences Acquisition Corporation Unit (FLACU) in Q4 2022, closing a stake of 1,000,000 shares — an estimated $9.98M sold.

RA Capital Management first reported a position in FLACU in Q4 2020 and held it in 8 quarters. The position peaked at $10.4M in Q4 2020. 0 funds tracked by Wall St. Rank hold FLACU as of Q4 2022.

RA Capital Management reported no remaining Frazier Lifesciences Acquisition Corporation Unit position as of Q4 2022 after selling out during the quarter.
RA Capital Management sold 1,000,000 Frazier Lifesciences Acquisition Corporation Unit shares in Q4 2022, an estimated $9.98M.
RA Capital Management first reported a position in Frazier Lifesciences Acquisition Corporation Unit in Q4 2020 and held it in 8 quarters.
RA Capital Management's Frazier Lifesciences Acquisition Corporation Unit position peaked at $10.4M in Q4 2020.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Unit as of Q4 2022.

Based on RA Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.